CVB.AU Curvebeam Ai Ltd
- Market cap
- AUD 6.59M
- P/E
- -
- P/B
- 0.53x
- ROE
- -67.8%
- Dividend yield
- -
- Fundamental score
- 0.7/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is CVB.AU undervalued?
Graham numberThe Graham number of Curvebeam Ai Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Curvebeam Ai Ltd fundamental analysis
4 of 21 checks passedROE 0/2
Low return on equity (-67.8%), below 10%.
ROA 0/1
Return on assets (-35.4%) is below the industry median (-35.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (8.8%) is below the industry median (24.9%).
Revenue Growth 1/2
Revenue grew 2.5% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (53.3%), up to 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 0/2
Cash covers 0.1 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.5x) is below the industry median (4.0x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Curvebeam Ai Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the …
Full company profileCurvebeam Ai Ltd financial statements
Curvebeam Ai Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 7.20M | 1.67M | 8.06M | 6.53M | 12.1M | 8.67M |
| Gross Profit | 3.22M | 1.67M | 4.39M | 3.01M | 5.43M | 2.85M |
| Operating Income | -7.62M | -8.54M | -52.0M | -23.1M | -16.8M | -20.4M |
| EBITDA | - | -9.04M | -43.5M | -18.6M | - | -14.9M |
| Net Income | -6.75M | -8.55M | -52.0M | -23.1M | -16.8M | -18.8M |
| EPS | -0.02 | -0.03 | -0.75 | -0.07 | -0.04 | -0.04 |
| Balance Sheet | ||||||
| Total Assets | 0.00 | 0.00 | 61.4M | 63.3M | 61.0M | 53.2M |
| Total Liabilities | 0.00 | 0.00 | 109M | 24.4M | 25.9M | 25.4M |
| Shareholders' Equity | 0.00 | 0.00 | -48.1M | 38.9M | 35.1M | 27.8M |
| Cash & Short-term Investments | - | - | 5.16M | 6.45M | 5.04M | 1.64M |
| Cash Flow | ||||||
| Operating Cash Flow | - | -7.99M | -21.7M | -21.9M | -11.2M | - |
| Capital Expenditure | 295K | 257K | 842K | 324K | 489K | 15.3K |
| Free Cash Flow | -4.83M | -10.5M | -22.5M | -22.2M | - | -13.0M |
| Ratios | ||||||
| ROE | - | - | - | -59.4% | -48.0% | -67.8% |
| ROA | - | - | -84.8% | -36.5% | -27.6% | -35.4% |
| Net Profit Margin | -93.7% | -511.1% | -646.1% | -353.9% | -139.2% | -217.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Curvebeam Ai Ltd dividends
Curvebeam Ai Ltd has not paid dividends in the last 6 fiscal years.
Who owns Curvebeam Ai Ltd
- Insiders 41.33%
- Institutions 15.02%
- Public & others 43.65%
- Shares outstanding 387M
- Free float 266M
Curvebeam Ai Ltd company profile
- Company name
- Curvebeam Ai Ltd
- Ticker
- CVB.AU
- ISIN
- AU0000289761
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- June
- Address
- 2800 Bronze Drive, Hatfield, PA, United States, 19440
- Phone
- 267 483 8081
- Website
- curvebeamai.com
About Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
Curvebeam Ai Ltd management
9- Mr. Gregory Wayne Brown BSc, MBACEO, MD & Director · born 1964
- Mr. Ura Phillip Stephen AucklandCFO & Company Secretary
- Mr. Arun Bahadur SinghCOO, CTO, President of US & Europe Division and Executive Director · born 1959
- Dr. Aloys MbalaCo-Founder
- Mr. Ali GhasemzadehCo-Founder
- Mr. S. Turner DeanChief Sales Officer
- Ms. Vinti SinghVice President of Marketing
- Dr. Yu Peng B.S., Ph.D.Chief Technology Officer (Artificial Intelligence) & Executive Director
- Prof. Ego SeemanMedical Director - Endocrinology